Connective tissue disease

Results: 197



#Item
161Juvenile Dermatomyositis WHAT IS DERMATOMYOSITIS? Juvenile dermatomyositis is an inflammatory disease of the muscle (myositis), skin and blood vessels that affects about 3 in 1 million children each year. The cause is un

Juvenile Dermatomyositis WHAT IS DERMATOMYOSITIS? Juvenile dermatomyositis is an inflammatory disease of the muscle (myositis), skin and blood vessels that affects about 3 in 1 million children each year. The cause is un

Add to Reading List

Source URL: www.rheumatology.org

Language: English
162BRFSS Brief Number 1305 The Behavioral Risk Factor Surveillance System (BRFSS) is an annual statewide telephone survey of adults developed by the Centers for Disease Control and Prevention and administered by the New Yor

BRFSS Brief Number 1305 The Behavioral Risk Factor Surveillance System (BRFSS) is an annual statewide telephone survey of adults developed by the Centers for Disease Control and Prevention and administered by the New Yor

Add to Reading List

Source URL: www.health.ny.gov

Language: English - Date: 2013-08-06 16:01:10
163American College of Rheumatology  Five Things Physicians and Patients Should Question Don’t test ANA sub-serologies without a positive ANA and clinical suspicion of immune-mediated disease.

American College of Rheumatology Five Things Physicians and Patients Should Question Don’t test ANA sub-serologies without a positive ANA and clinical suspicion of immune-mediated disease.

Add to Reading List

Source URL: www.rheumatology.org

Language: English
164Provincial Drug Programs P. O. Box 2000 Charlottetown PE C1A 7N8[removed]Toll Free on PEI)  Programmes provinciaux de médicaments

Provincial Drug Programs P. O. Box 2000 Charlottetown PE C1A 7N8[removed]Toll Free on PEI) Programmes provinciaux de médicaments

Add to Reading List

Source URL: www.gov.pe.ca

Language: English - Date: 2013-09-18 09:47:25
165Microsoft Word - OI Overview 5-13

Microsoft Word - OI Overview 5-13

Add to Reading List

Source URL: www.niams.nih.gov

Language: English - Date: 2013-08-23 13:35:18
166TH[removed]NE 15 AVE · PORTLAND, OR 97211 · FAX: ([removed] · ([removed] · [removed] · VESTIBULAR.ORG Autoimmune Inner Ear Disease (AIED)

TH[removed]NE 15 AVE · PORTLAND, OR 97211 · FAX: ([removed] · ([removed] · [removed] · VESTIBULAR.ORG Autoimmune Inner Ear Disease (AIED)

Add to Reading List

Source URL: vestibular.org

Language: English - Date: 2014-03-18 17:43:34
167Provincial Drug Programs P. O. Box 2000 Charlottetown PE C1A 7N8[removed]Toll Free on PEI)  Programmes provinciaux de médicaments

Provincial Drug Programs P. O. Box 2000 Charlottetown PE C1A 7N8[removed]Toll Free on PEI) Programmes provinciaux de médicaments

Add to Reading List

Source URL: www.gov.pe.ca

Language: English - Date: 2013-05-07 09:42:59
168Osteoarthritis  Introduction Osteoarthritis is a common disease that affects about 20 million Americans and is the #1 cause of disability in America. Osteoarthritis, also called degenerative arthritis, results from wear

Osteoarthritis Introduction Osteoarthritis is a common disease that affects about 20 million Americans and is the #1 cause of disability in America. Osteoarthritis, also called degenerative arthritis, results from wear

Add to Reading List

Source URL: www.nlm.nih.gov

Language: English - Date: 2014-04-30 11:19:11
169ACHES Screening and Consent Script  INTRODUCTION: Hello, I’m ________________, calling on behalf of the Centers for Disease Control and Prevention. We are conducting a study to learn more about people with specific hea

ACHES Screening and Consent Script INTRODUCTION: Hello, I’m ________________, calling on behalf of the Centers for Disease Control and Prevention. We are conducting a study to learn more about people with specific hea

Add to Reading List

Source URL: www.cdc.gov

Language: English - Date: 2014-02-27 14:53:19
170Guidance for Industry Clinical Development Programs for Drugs, Devices, and Biological Products for the Treatment of Rheumatoid Arthritis (RA)

Guidance for Industry Clinical Development Programs for Drugs, Devices, and Biological Products for the Treatment of Rheumatoid Arthritis (RA)

Add to Reading List

Source URL: www.fda.gov

Language: English